Chen Q, Jones T W, Stevens J L
W. Alton Jones Cell Science Center, Lake Placid, New York 12946.
J Cell Physiol. 1994 Nov;161(2):293-302. doi: 10.1002/jcp.1041610214.
Addition of the nephrotoxic cysteine conjugate, S-(1,2-dichlorovinyl)-L-cysteine (DCVC), to the LLC-PK1 line of renal epithelial cells leads to covalent binding of reactive intermediates followed by thiol depletion, lipid peroxidation, and cell death (Chen et al., 1990, J. Biol. Chem., 265:21603-21611). The present study was designed to determine if increased intracellular free calcium might play a role in this pathway of DCVC-induced toxicity by comparing the temporal relationships among increased intracellular free calcium, lipid peroxidation, and cytotoxicity. Intracellular free calcium increased 1 hr after DCVC treatment, long before LDH release occurred. The elevation of intracellular free calcium and cytotoxicity was prevented by inhibiting DCVC metabolism with AOA. The cell-permeable chelators, Quin-2AM and EGTA-AM, prevented the toxicity. Pretreatment of cells with a nontoxic concentration of ionomycin increased intracellular free calcium and potentiated DCVC-induced LDH release. However, the antioxidant, DPPD, which blocks lipid peroxidation and toxicity, did not affect the increase in intracellular free calcium, whereas buffering intracellular calcium with Quin-2AM or EGTA-AM blocked both lipid peroxidation and toxicity without preventing the depletion of nonprotein sulfhydryls by DCVC. Ruthenium red, an inhibitor of mitochondrial calcium uptake, also blocked cell death. We hypothesize that covalent binding of the reactive fragment from DCVC metabolism leads to deregulation of intracellular calcium homeostasis and elevation of intracellular free calcium. Increased intracellular free calcium may in turn be coupled to mitochondrial damage and the accumulation of endogenous oxidants which cause lipid peroxidation and cell death.
向肾上皮细胞系LLC-PK1中添加肾毒性半胱氨酸共轭物S-(1,2-二氯乙烯基)-L-半胱氨酸(DCVC),会导致反应性中间体的共价结合,随后出现巯基耗竭、脂质过氧化和细胞死亡(Chen等人,1990年,《生物化学杂志》,265:21603 - 21611)。本研究旨在通过比较细胞内游离钙增加、脂质过氧化和细胞毒性之间的时间关系,确定细胞内游离钙增加是否在DCVC诱导的毒性途径中起作用。DCVC处理1小时后细胞内游离钙增加,远早于乳酸脱氢酶(LDH)释放。用氨基氧乙酸(AOA)抑制DCVC代谢可防止细胞内游离钙升高和细胞毒性。细胞可渗透螯合剂喹啉-2-乙酰甲酯(Quin-2AM)和乙二醇双四乙酸乙酰甲酯(EGTA-AM)可防止毒性。用无毒浓度的离子霉素预处理细胞可增加细胞内游离钙,并增强DCVC诱导的LDH释放。然而,阻断脂质过氧化和毒性的抗氧化剂二苯基对苯二胺(DPPD)并不影响细胞内游离钙的增加,而用Quin-2AM或EGTA-AM缓冲细胞内钙可阻断脂质过氧化和毒性,却不能防止DCVC导致的非蛋白巯基耗竭。线粒体钙摄取抑制剂钌红也可阻断细胞死亡。我们推测,DCVC代谢产生的反应性片段的共价结合会导致细胞内钙稳态失调和细胞内游离钙升高。细胞内游离钙增加可能进而与线粒体损伤和内源性氧化剂的积累相关联,从而导致脂质过氧化和细胞死亡。